Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes

Tuberculosis (TB) is a global health concern. Treatment is prolonged, and patients on anti-TB therapy (ATT) often experience treatment failure for various reasons. There is an urgent need to identify signatures for early detection of failure and initiation of a treatment switch. We investigated how...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Commun Biol
Päätekijät: Sivakumaran, Dhanasekaran, Jenum, Synne, Vaz, Mario, Selvam, Sumithra, Ottenhoff, Tom H. M., Haks, Marielle C., Malherbe, Stephanus T., Doherty, T. Mark, Ritz, Christian, Grewal, Harleen M. S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347567/
https://ncbi.nlm.nih.gov/pubmed/32647325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-020-1087-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia